Difference between revisions of "Lithium"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drug | name = lithium | group = mood stabilizer | type = Moodstabilizer | medscape = 5887 | pubchem = 11125 | drugscom = lithium | wikipedia = Lithium_pharmacology | ATC =...')
 
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
{{Drug
 
{{Drug
| name = lithium
+
| name = Lithium
| group = mood stabilizer
+
| group = other
| type = Moodstabilizer
+
| type = moodstabilizer
 
| medscape = 5887
 
| medscape = 5887
 
| pubchem = 11125
 
| pubchem = 11125
Line 8: Line 8:
 
| wikipedia = Lithium_pharmacology
 
| wikipedia = Lithium_pharmacology
 
| ATC = N05AN01
 
| ATC = N05AN01
| administration = Oral
+
| metabolization =  
| cth = 0.4-1.2 mmol/L
+
* Lithium is eliminated by the kidney for about 95%. Changes in the rate of excretion can cause unwanted effects.
| cth_ref =
+
| administration = O
| ctox = 1.5 mmol/L
 
| ctox_ref = <ref name="ftktox">{{ftktox}}</ref>
 
 
| halflife = 12-48
 
| halflife = 12-48
 
| halflife_ref = <ref name="ftk">{{FTK|lithium}}</ref>
 
| halflife_ref = <ref name="ftk">{{FTK|lithium}}</ref>
| metabolites = 0
+
|<includeonly> isswitch = 1 </includeonly>
| bioavailability =
 
| dose =
 
| DDD =
 
| dmax =
 
|
 
| renal = 6
 
| renal_ref = <ref name="ftk" /><ref name="informatorium">{{KNMP|lithium}} </ref>
 
| hepatic = 0
 
| children = 1
 
| children_ref = <ref>{{NKFK|283}}</ref>
 
| eldery = 8
 
| eldery_ref = <ref name="drugscom">{{DRUGSCOM|lithium}}</ref>
 
| lqts = 6
 
| lqts_ref = <ref name="hsuch"> {{Pubmed|15591709|Hsu CH et al. Electrocardiographic abnormalities as predictors for over-range lithium levels. ''Cardiology'' 2005;103(2):101-6}} </ref>
 
| diabetes = 4
 
| diabetes_ref = <ref name="ftk">{{FTK|lithium}}</ref>
 
| cvd =
 
| heartfailure = 
 
| cva =
 
| seizures =
 
| pregnancy = 8
 
| pregnancy_ref = <ref name="drugscom" />
 
| pharmacogenetics =
 
| lactation = 10
 
| lactation_ref = <ref name="ftk" />
 
| traffic = 6
 
| traffic_ref = <ref name="ftk" /><ref>{{Verkeer|anti-epileptica/13-lithium-camcolit-litarex-lihiumcarbonaat-priadel-ii|lithium-camcolit-litarex-lihiumcarbonaat-priadel}}</ref>
 
| anticholinergic = 0
 
| sexmale = 0
 
| sexfemale = 0
 
| fertility =
 
| gynaecology =
 
| dyskinesia = 10
 
| dyskinesia_ref = <ref name="informatorium">{{KNMP|lithium}} </ref>
 
| haematology =
 
| weight = 10
 
| weight_ref = <ref name="informatorium" /><ref name="torrentc"> {{Pubmed|18498432|Torrent C et al. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. ''Acta Psychiatr Scand'' 2008 jul;118(1):4-18 }}</ref>
 
| sedation = 0
 
<includeonly>
 
| isswitch = 1
 
</includeonly>
 
 
}}
 
}}

Latest revision as of 00:01, 27 April 2010

Lithium
Type moodstabilizer
Group other
links
ATC-code N05AN01
Medscape Lithium
PubChem 11125
PubMed Lithium
Drugs.com lithium
Kompas (Dutch) Lithium
Wikipedia Lithium

"-48" can not be assigned to a declared number type with value 12.






Lithium is a moodstabilizer in the group other.


Metabolization
  • Lithium is eliminated by the kidney for about 95%. Changes in the rate of excretion can cause unwanted effects.